Testicular Autoimmunity by the Systemic Treatment with Immuno-Potentiating Agents in Experimental Animals
Reference200 articles.
1. Adekunle AO, Hickey WF, Smith SM, Tung KSK, Teuscher C. Experimental allergic orchitis in mice IV. Preliminary characterization of the major murine testis specific aspermatogenic autoantigen(s). J Reprod Immunol. 1987;12:49–62. 2. Aslani F, Schuppe HC, Guazzone VA, Bhushan S, Wahle E, Lochnit G, Lustig L, Meinhardt A, Fijak M. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis. Hum Reprod. 2014.; pii: deu320 3. Audia S, Nicolas A, Cathelin D, Larmonier N, Ferrand C, Foucher P, Fanton A, Bergoin E, Maynadie M, Arnould L, Bateman A, Lorcerie B, Solary E, Chauffert B, Bonnotte B. Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes. Clin Exp Immunol. 2007;150:523–30. 4. Bassi N, Luisetto R, Del Prete D, Ghirardello A, Ceol M, Rizzo S, Laccarino L, Gatto M, Valente ML, Punzi L, Doria A. Induction of ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund’s adjuvant (CFA). Lupus. 2012;21:203–9. 5. Ben K, Alexander NJ, Huso N. In vitro cell-mediated and complement-mediated cytotoxicity to murine testicular cells. Am J Reprod Immunol. 1986;12:33–7.
|
|